For researchers, this consolidation creates a paradoxically better environment: the average quality of available suppliers has increased, because the market-clearing event removed the least compliant, least transparent, and most risk-prone operators
Stark R, Feehan J, Mousa A, Andrews ZB, de Courten B
proglucagon is expressed in the pancreas
Although diet interventions in humans are difficult to maintain weight loss, mice respond to caloric restriction (CR) well
Theres no single reform that protects consumer safety
If a consumer can buy Wegovy or Zepbound for $350 directly from the manufacturer, employers are right to ask: Why should our health plan pay more than an individual paying cash? This transparency sets the stage for employers to push for: Mid-cycle GLP-1 repricing or rebate true-ups Most-favored-net clauses guaranteeing parity with manufacturer DTC pricing Dose-specific caps to prevent runaway spend as members titrate upward Even without an immediate financial impact, this public price signal changes the tone of employer-PBM negotiations heading into 2026
